So when do you arrive?
For many American buyers, the French Riviera still carries an aura of unattainable glamour — yachts in the harbor, Belle Époque villas on sunlit hillsides, and cafés overlooking the Mediterranean. But when you compare property prices along the Riviera with those in many famous U.S. coastal markets, the numbers can be surprisingly competitive.
In fact, a well-located apartment overlooking the Mediterranean in towns like Villefranche-sur-Mer or Beaulieu-sur-Mer can sometimes cost less than comparable properties in parts of coastal California or Florida — while offering a level of lifestyle and scenery that few places in the United States can match.
Take a look at some of America’s most coveted coastal real estate markets. In Malibu, beachfront homes regularly sell for several million dollars, with even modest ocean-view properties often priced well above $5 million. Along the East Coast in The Hamptons, summer homes have become synonymous with ultra-wealthy buyers, pushing prices into the multi-million-dollar range for prime properties.
Further south, Miami continues to attract international buyers with its luxury condos and waterfront mansions. Prices in desirable neighborhoods or beachfront towers frequently rival those in global resort destinations. Even in smaller but highly desirable markets like Santa Barbara, the cost of entry for an ocean-view property can quickly climb into the millions.
For American buyers accustomed to these markets, the French Riviera can come as a pleasant surprise.
Along the Mediterranean coast of southern France, property prices vary widely depending on location, views, and proximity to the sea. Yet many Riviera towns still offer remarkable value compared with their American counterparts.
In the charming harbor town of Villefranche-sur-Mer, buyers can find elegant apartments with sweeping views over one of the Riviera’s most beautiful bays — often at prices that compare favorably with mid-range condos in Miami or Southern California.
Just a few minutes away, Beaulieu-sur-Mer offers a refined seaside atmosphere, palm-lined promenades, and classic Riviera architecture. Properties here provide easy access to the sea, marinas, and restaurants while sitting between two of the most prestigious destinations in Europe: Nice and Monaco.
Further west along the coast, internationally known destinations like Cannes and Cap d’Antibes continue to attract buyers from around the world. Cannes, famous for its film festival and sandy beaches, offers a wide range of luxury apartments and villas, while Cap d’Antibes remains one of the Riviera’s most exclusive residential enclaves, with grand estates tucked among pine trees and overlooking turquoise coves.
For American buyers used to paying a premium for coastal living, the idea of owning a Mediterranean property in such locations can feel unexpectedly attainable.
Of course, real estate value is about more than just square footage. What sets the Riviera apart is the lifestyle that comes with it.
Residents enjoy mild winters, warm summers, and easy access to beaches, mountain villages, and cultural destinations. The region is anchored by Nice Côte d’Azur Airport, which provides direct connections to major European cities and long-haul flights to North America.
A morning might begin with a walk through a local market, followed by lunch at a seaside restaurant and an afternoon swim in the Mediterranean — all within minutes of home.
Despite its reputation for luxury, the French Riviera remains a place of small harbors, family-run cafés, and centuries-old villages. In towns like Villefranche-sur-Mer and Beaulieu-sur-Mer — as well as prestigious addresses such as Cannes and Cap d’Antibes — life moves at a slower, more refined pace than in many major American coastal cities.
For U.S. buyers considering property abroad, this balance of beauty, culture, and relative value is becoming increasingly appealing.
The Riviera may have long been associated with movie stars and royalty, but today many international buyers are discovering that owning a piece of the Mediterranean lifestyle can be far more achievable than they imagined. In a world where coastal real estate prices continue to climb, the French Riviera still offers something rare: timeless beauty paired with surprisingly competitive value.
France has confirmed it will dramatically reduce its financial contribution to the global fight against HIV/AIDS, a decision that is already drawing fierce criticism from public health organizations and political leaders. The cuts will push France from the world’s second-largest contributor to fifth place, marking a sharp reversal from the leadership role it once claimed in global health efforts.
The French government confirmed that between 2026 and 2028 it plans to contribute €860 million combined to the Global Fund and Unitaid, two of the world’s main organizations financing the fight against HIV/AIDS, tuberculosis, and malaria.
That figure represents a reduction of more than half of France’s previous commitment. During the last funding cycle from 2023 to 2025, France pledged €1.6 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria alone, plus an additional €255 million to Unitaid.
The decision confirms earlier reports revealed in February and effectively ends hopes that Paris might reverse course ahead of the upcoming One Health Summit, which President Emmanuel Macron is scheduled to open in Lyon.
Officials say the decision is driven by France’s deteriorating public finances.
According to the Ministry of Foreign Affairs, the government is attempting to reduce the national deficit to 5% of GDP by 2026, forcing significant spending cuts across multiple sectors.
“Public finances are currently under considerable pressure,” the ministry said in a statement. Despite the cuts, it insisted that global health remains a priority area of France’s international solidarity policy.
Critics, however, say the numbers tell a different story.
Nine HIV/AIDS organizations condemned the move in a joint statement, calling it a dangerous retreat from global health leadership.
“France is abandoning millions of people,” said Camille Spire, president of the French HIV advocacy group AIDES.
“This is the largest reduction among all G7 countries,” added Florence Thune, head of Sidaction. “France is effectively deserting the global fight against pandemics.”
The cuts will have immediate geopolitical implications as well. France’s reduced commitment now places it behind the United States, Germany, and the United Kingdom, and even behind the philanthropic funding of the Bill & Melinda Gates Foundation, which pledged €788 million.
The decision is also facing criticism inside France’s parliament.
On February 3, the National Assembly of France unanimously passed a resolution calling on the government to maintain strong financial support in the global fight against HIV/AIDS.
The measure, introduced by Socialist MP Arthur Delaporte, passed with all 135 votes in favor, though it is not legally binding.
Delaporte urged the government to reconsider the cuts, warning that France risks abandoning its long-standing international role in global health.
“The government is choosing to follow the same unfortunate path as Donald Trump,” he said.
His comment refers to the recent reduction in U.S. funding for global HIV programs. Since Trump returned to the White House, the United States — historically the world’s largest contributor — has reportedly reduced its global HIV/AIDS funding from $6 billion to $4.6 billion.
Public health experts say the symbolism of France’s decision may be as damaging as the financial impact.
For years, France positioned itself as one of the key champions of global HIV/AIDS programs. That reputation was cemented in 2019 when France hosted a major replenishment conference for the Global Fund to Fight AIDS, Tuberculosis and Malaria in Lyon.
At the time, President Emmanuel Macron delivered a passionate speech urging world leaders to intensify their efforts.
“The goal of ending the epidemic by 2030 is achievable,” he said then. “But only if we live up to our responsibilities today.”
Many activists now say those words ring hollow.
Advocacy groups warn that the combination of reduced funding from both the United States and France could derail global efforts to eliminate HIV/AIDS as a public health threat by 2030.
“Who can still believe the epidemic will end by 2030?” asked the French advocacy group Actions Traitements.
“What once seemed achievable just a few years ago is quickly becoming impossible.”
The Global Fund to Fight AIDS, Tuberculosis and Malaria had hoped to raise $18 billion for its next three-year funding cycle, but current pledges suggest the total may fall below $13 billion — a shortfall that could directly impact treatment, prevention programs, and lifesaving medication in many parts of the world.
For critics, the concern is simple: when major donors pull back, the consequences are measured not just in budgets — but in lives.